Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy

References

• SiegelRLMillerKDJemalACancer Statistics, 2017CA cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• BlowsFMDriverKESchmidtMKSubtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studiesPLoS Med201075e100027920520800
   PubMed Web of Science ®Google Scholar
• HafftyBGYangQReissMLocoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancerJ Clin Oncol200624365652565717116942
   PubMed Web of Science ®Google Scholar
• PerezEAMoreno-AspitiaAAubrey ThompsonEAndorferCAAdjuvant therapy of triple negative breast cancerBreast Cancer Res Treat2010120228529120094772
   PubMed Web of Science ®Google Scholar
• VernieriCMilanoMMennittoAAntitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective studyBreast Cancer Res Treat2017165236537328616768
   PubMed Web of Science ®Google Scholar
• FerreiraARMetzger-FilhoOSarmentoRMBBinesJNeoadjuvant Treatment of Stage IIB/III Triple Negative Breast Cancer with Cyclophosphamide, Doxorubicin, and Cisplatin (CAP Regimen): A Single Arm, Single Center Phase II Study (GBECAM 2008/02)Front Oncol2017732929416986
   PubMed Web of Science ®Google Scholar
• La BelleAKhatibJSchiemannWPVinayakSRole of Platinum in Early-Stage Triple-Negative Breast CancerCurr Treat Options Oncol201718116829110096
   PubMed Web of Science ®Google Scholar
• SaraivaDPGuadalupe CabralMJacintoABragaSHow many diseases is triple negative breast cancer: the protagonism of the immune microenvironmentESMO Open201724e00020829018573
   PubMed Web of Science ®Google Scholar
• FuJBianMJiangQZhangCRoles of Aurora kinases in mitosis and tumorigenesisMol Cancer Res20075111017259342
   PubMed Web of Science ®Google Scholar
• SugimotoKUranoTZushiHMolecular dynamics of Aurora-A kinase in living mitotic cells simultaneously visualized with histone H3 and nuclear membrane protein importinalphaCell Struct Funct200227645746712576638
   PubMed Web of Science ®Google Scholar
• XuZOgawaHVagnarelliPINCENP-aurora B interactions modulate kinase activity and chromosome passenger complex localizationJ Cell Biol2009187563765319951914
   PubMed Web of Science ®Google Scholar
• MarumotoTZhangDSayaHAurora-A - a guardian of polesNat Rev Cancer200551425015630414
   PubMed Web of Science ®Google Scholar
• KovarikovaVBurkusJRehakPBrzakovaASolcPBaranVAurora kinase A is essential for correct chromosome segregation in mouse zygoteZygote201624332633726174602
   PubMed Web of Science ®Google Scholar
• QinKWuCWuXTwo nonsynonymous polymorphisms (F31I and V57I) of the STK15 gene and breast cancer risk: a meta-analysis based on 5966 cases and 7609 controlsJ Int Med Res201341495696323803310
   PubMed Web of Science ®Google Scholar
• PanJYAjaniJAGuJAssociation of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiationCancer2012118174346435322213102
   PubMed Web of Science ®Google Scholar
• HammondMEHayesDFDowsettMAmerican Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancerJ Clin Oncol201028162784279520404251
   PubMed Web of Science ®Google Scholar
• WolffACHammondMEHicksDGRecommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline updateJ Clin Oncol201331313997401324101045
   PubMed Web of Science ®Google Scholar
• XiuLZhangCWuZPengJEstablishment and Application of a Universal Coronavirus Screening Method Using MALDI-TOF Mass SpectrometryFront Microbiol20178151028848521
   PubMed Web of Science ®Google Scholar
• CheungKWPengQHeLRapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® SystemPLoS One2016114e015364127092551
   PubMed Web of Science ®Google Scholar
• FletcherOJohnsonNPallesCInconsistent association between the STK15 F31I genetic polymorphism and breast cancer riskJ Natl Cancer Inst200698141014101816849685
   PubMedGoogle Scholar
• CoxDGHankinsonSEHunterDJPolymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States)Cancer Causes Control2006171818316411056
   PubMed Web of Science ®Google Scholar
• RuanYSongAPWangHGenetic polymorphisms in AURKA and BRCA1 are associated with breast cancer susceptibility in a Chinese Han populationJ Pathol2011225453554321598251
   PubMed Web of Science ®Google Scholar
• TaylorNJBensenJTPooleCGenetic variation in cell cycle regulatory gene AURKA and association with intrinsic breast cancer subtypeMol Carcinog201554121668167725328151
   PubMed Web of Science ®Google Scholar
• ShiHBevierMJohanssonRSingle nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcomeBreast Cancer Res Treat2011130390591621630024
   PubMed Web of Science ®Google Scholar
• NadlerYCampRLSchwartzCRimmDLKlugerHMKlugerYExpression of Aurora A (but not Aurora B) is predictive of survival in breast cancerClin Cancer Res200814144455446218628459
   PubMed Web of Science ®Google Scholar
• XuJWuXZhouWHAurora-A identifies early recurrence and poor prognosis and promises a potential therapeutic target in triple negative breast cancerPLoS One201382e5691923437271
   PubMed Web of Science ®Google Scholar
• MarumotoTHondaSHaraTAurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cellsJ Biol Chem200327851517865179514523000
   PubMed Web of Science ®Google Scholar
• TentlerJJIonkinaAATanACp53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast CancerMol Cancer Ther20151451117112925758253
   PubMed Web of Science ®Google Scholar
• TchatchouSWirtenbergerMHemminkiKAurora kinases A and B and familial breast cancer riskCancer Lett2007247226627216762494
   PubMed Web of Science ®Google Scholar
• ZhangYJiangCLiHElevated Aurora B expression contributes to chemoresistance and poor prognosis in breast cancerInt J Clin Exp Pathol20158175175725755770
   PubMed Web of Science ®Google Scholar
• LiYTangKZhangHZhangYZhouWChenXFunction of Aurora kinase A in Taxol-resistant breast cancer and its correlation with P-gpMol Med Rep20114473974621584498
   PubMed Web of Science ®Google Scholar
• MonzóMRosellRSánchezJJPaclitaxel resistance in non- small-cell lung cancer associated with beta-tubulin gene mutationsJ Clin Oncol19991761786179310561216
   PubMed Web of Science ®Google Scholar
• MesicAMarkocicERogarMJuvanRHudlerPKomelRSingle nucleotide polymorphisms rs911160 in AURKA and rs2289590 in AURKB mitotic checkpoint genes contribute to gastric cancer susceptibilityEnviron Mol Mutagen201758970171128843004
   PubMed Web of Science ®Google Scholar
• GordonSAkopyanGGarbanHBonavidaBTranscription factor YY1: structure, function, and therapeutic implications in cancer biologyOncogene20062581125114216314846
   PubMed Web of Science ®Google Scholar